← Back to All Filings

Medpace Holdings Director Robert O. Kraft Acquires Shares via RSU Vesting

Low SignificanceOctober 2, 2026 at 9:53:39 PM UTC

Medpace Holdings, Inc.

$MEDP4CIK: 0001668397

Subscribe to track MEDP

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Medpace Holdings, Inc. ($MEDP) Form 4 Filing Insider: Robert O. Kraft (Director) Transaction Date: 2026-09-30 Type: Acquisition via RSU Vesting (Code M) Shares Transacted: 32 shares Price per Share: $0.00 Total Value: $0.00 Post-Transaction Ownership: 987 shares (Direct) Significance: Low (Routine quarterly RSU vesting schedule)

Comprehensive Analysis

Executive Summary

On October 2, 2026, Medpace Holdings, Inc. ($MEDP) filed a Form 4 on behalf of Director Robert O. Kraft reporting the vesting and settlement of 32 Restricted Stock Units (RSUs) on September 30, 2026. This transaction reflects routine equity compensation vesting and does not involve open-market purchasing or selling activity.

Transaction Breakdown

  • Security: Common Stock
  • Transaction Code: M (Exercise or conversion of derivative security exempted pursuant to Rule 16b-3)
  • Shares Acquired: 32
  • Transaction Price: $0.00 (settlement of RSUs granted on November 28, 2025)
  • Total Consideration: $0.00
  • Post-Transaction Direct Ownership: 987 Common Stock shares (with 32 unvested RSUs remaining from the original 130-unit award scheduled to vest on December 31, 2026)

Trading Significance

This filing carries Low trading significance. It represents a scheduled, non-discretionary vesting tranche of director compensation rather than an open-market trade reflecting discretionary insider sentiment.

Topics:#MEDP#Medpace#InsiderTrading#Form4#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.